Flow cytometric S-phase fraction measurement in breast carcinoma: Influence of software and histogram resolution
- 20 May 2002
- Vol. 48 (2) , 66-70
- https://doi.org/10.1002/cyto.10116
Abstract
S-phase fraction (SPF) measurement by flow cytometry is a clinically useful prognostic factor in patients with breast carcinoma. Standardized SPF determination is essential. As part of a multicenter study, we evaluated the influence of the choice of software and histogram resolution (256, 512, or 1,024 channels) on SPF quantification.One hundred thirty-three DNA histograms were analyzed in three laboratories with Modfit 5.2, Modfit LT, and Multicycle AV software. Strict rules for histogram interpretation and software management were applied. The following five options were compared: MF 5.2 1024, MF 5.2 256, MF LT 256, MC AV 256, and MC AV 512.In the DNA diploid and aneuploid groups, SPF distributions were not statistically different among the five options. Excellent quantitative correlations were obtained between pairs of options. When using tertiles as cutpoints for SPF classification, concordance rates ranged from 79.7% to 93.2% for DNA diploid samples and from 87.8% to 95.9% for DNA aneuploid samples, the best results being obtained with software working with a similar histogram resolution.Standardized use of commercially available software, including the choice of histogram resolution, provides comparable SPF results.Keywords
Funding Information
- Ministère Français de la Santé
This publication has 25 references indexed in Scilit:
- Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activityBreast Cancer Research and Treatment, 2000
- S-phase fraction and breast cancer - a decade of experienceBreast Cancer Research and Treatment, 1998
- Quality control study by the French Cytometry Association on flow cytometric DNA content and S-phase fraction (S%)Cytometry, 1996
- Flow cytometry in node‐positive breast cancer: Cancer and leukemia group B protocol 8869Cytometry, 1995
- The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centreBritish Journal of Cancer, 1995
- S-phase fraction and nuclear size in long term prognosis of patients with breast cancerCancer, 1994
- Dna flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancerCancer, 1993
- Consensus review of the clinical utility of dna cytometry in carcinoma of the breastCytometry, 1993
- Guidelines for implementation of clinical DNA cytometryCytometry, 1993
- Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.Journal of Clinical Oncology, 1992